IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro

Journal of Clinical Investigation

Volumn 98, Issue 3, 1996, Pages 715-722

  Bhardwaj, Nina ^a,b   Seder, Robert A ^c   Reddy, Anita ^a   Feldman, Mary V ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

CD8+ T cells; cytolytic T cells; dendritic cells; interleukin 12; vaccines

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CYTOLYSIS; DENDRITIC CELL; DISEASE CONTROL; DISEASE MODEL; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLUENZA VIRUS A; MAJOR HISTOCOMPATIBILITY COMPLEX; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL;

EID: 0029928322     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118843     Document Type: Article

References (43)

1. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.
2. Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 84:4008-4027.
3. Scharton, T.M., and P. Scott. 1993. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178:567-577.
4. Chehimi, J., N.M. Valiante, A. D'Andrea, M. Rengaraju, Z. Rosado, M. Koyayashi, B. Perussia, S.F. Wolf, S.E. Starr, and G. Trinchieri. 1993. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur. J. Immunol. 23:1826-1830.
5. Chan, S.H., B. Perussia, J.W. Gupta, M. Kobayashi, M. Pospisil, H.A. Young, S.F. Wolf, D. Young, S.C. Clark, and G. Trinchieri. 1991. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173: 869-879.
6. Kobayashi, M., L. Fitz, M. Ryan, R.M. Hewick, S.C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827-845.
7. Gately, M.K., B.B. Desai, A.G. Wolitzky, P.M. Ouinn, C.M. Dwyer, F.J. Podlaski, P.C. Familletti, F. Sinigaglia, R. Chizonnite, U. Gubler, and A.S. Stern. 1991. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147:874-882.
8. Seder, R.A., and W.E. Paul. 1994. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12:635-673.
9. Gately, M.K., A.G. Wolitzky, P.M. Quinn, and R. Chizzonite. 1992. Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell. Immunol. 143:127-142.
10. Chouaib, S., J. Chehimi, L. Bani, N. Genetet, T. Tursz, F. Gay, G. Trinchieri, and F. Mami-Chouaib. 1994. Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precurosrs into allospecific cytotoxic effectors. Proc. Natl. Acad. Sci. USA. 91: 12659-12663.
11. Bloom, E.T., and J.A. Horvath. 1994. Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T cell activity. Implications for the age-related decline in CTL. J. Immunol. 152:4242-4254.
12. Mehrotra, P.T., D. Wu, J.A. Crim, H.S. Mostowski, and J.P. Siegel. 1993. Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes. J. Immunol. 151:2444-2452.
13. Bhardwaj, N., A. Bender, N. Gonzalez, L.K. Bui, M.C. Garrett, and R.M. Steinman. 1994. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J. Clin. Invest. 94:797-807.
14. + cytolytic T cell responses. J. Exp. Med. 182:1663-1671.
15. Macatonia, S.E., N.A. Hosken, M. Litton, P. Vieira, C. Hsieh, J.A. Culpepper, M. Wysocka, G. Trinchieri, K.M. Murphy, and A. O'Garra. 1995. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J. Immunol. 154:5071-5079.
16. Kang, K.F., M. Kubin, K.D. Cooper, S.R. Lessin, G. Trinchieri, and A.H. Rook. 1996. IL-12 synthesis by human Langerhans cells. J. Immunol. 156: 1402.
17. Kanangat, S., S. Nair, J.S. Babu, and B.T. Rouse. 1995. Expression of cytokine mRNA in murine splenic dendritic cells and better induction of T cell-derived cytokines by dendritic cells than by macrophages during in vitro costimulation assay using specific antigens. J. Leukocyte Biol. 57:310-316.
18. Carson, W.E., J.G. Giri, M.J. Lindemann, M.L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, and M.A. Caligiuri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1395-1403.
19. Seder, R.A., K.H. Grabstein, J.A. Berzofsky, and J.F. McDyer. 1995. Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin IL-2, IL-12, and IL-15. J. Exp. Med. 182:1067-1078.
20. Fesq, H., M. Bacher, M. Nain, and D. Gemsa. 1994. Programmed cell death (apoptosis) in human monocytes infected by influenza virus. Immunobiology 190:175-182.
21. Celis, E., V. Tsai, C. Crimi, R. DeMars, P.A. Wentworth, R.W. Chestnut, H.M. Grey, A. Sette, and H.M. Serra. 1994. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA. 91:2105-2109.
22. Steinman, R.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296.
23. Shu, D., M. Kiniwa, C.Y. Wu, C. Maliszewski, N. Vezzio, J. Hakimi, M. Gately, and G. Delespesse. 1995. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25: 1125-1128.
24. Stuber, E., W. Strober, and M. Neurath. 1996. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper I cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183:693-698.
25. + helper T cells. J. Exp. Med. 171:1315-1332.
26. Clerici, M., D.R. Lucey, J.A. Berzoksky, L.A. Pinto, T.A. Wynn, S.P. Blatt, M.J. Dolan, C.W. Hendrix, S.F. Wolf, and G.M. Shearer. 1993. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science (Wash. DC). 262:1721-1724.
27. Robertson, M.J., R.J. Soiffer, S.F. Wolf, T.J. Manley, C. Donahue, D. Young, S.H. Herrmann, and J. Ritz. 1992. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med. 175:779-788.
28. Orange, J.S., and C.A. Biron. 1996. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. J. Immunol. 156:1138-1142.
29. Muller, U., U. Steinhoff, L.F.L. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science (Wash. DC). 264:1918-1921.
30. Guidotti, L.G., T. Ishikawa, M.V. Hobbs, B. Matzke, R. Schreiber, and F.V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunology. 4:25-36.
31. Jonuleit, H., U. Kuhn, G. Muller, M. Wolfl, S. Lohmann, J. Saloga, D. Becker, J. Knop, and A.H. Enk. 1995. Keratinocyte-derived IL-15 enhances accessory functions of epidermal LC and blood dendritic cells. J. Invest. Dermatol. 105:861 (Abstr.).
32. Horohov, D.W., J.A. Crim, P.L. Smith, and J.P. Siegel. 1988. IL-4 (B cell-stimulatory factor 1) regulates multiple aspects of influenza virus-specific cell-mediated immunity. J. Immunol. 141:4217-4224.
33. D'Andrea, A., X. Ma, M. Aste-Amezaga, C. Paganin, and G. Trinchieri. 1995. Stimulatory and inhibitory effects of IL-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J. Exp. Med. 181:537-546.
34. Coutelier, J.-P., J. Van Broeck, and S.F. Wolf. 1995. Interleukin-12 gene expression after viral infection in the mouse. J. Virol. 69:1955-1958.
35. Orange, J.S., S.F. Wolf, and C.A. Biron. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152:1253.
36. Chehimi, J., S.E. Starr, I. Frank, A. D'Andrea, X. Ma, R.R. Macgregor, J. Sennelier, and G. Trinchieri. 1994. Impaired interleukin-12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361-1366.
37. Monteiro, J.M., and G. Trinchieri. 1995. Role of IL-12 in the in vivo immune response to influenza infection. In Interleukin 12: Cellular and Molecular Immunology of an Important Regulatory Cytokine. New York Acad. Sci. Conf. P24. (Abstr.)
38. Yamada, Y.K., A. Meager, A. Yamada, and F.A. Ennis. 1986. Human interferon alpha and gamma production by lymphocytes during the generation of influenza virus-specific cytotoxic T lymphocytes. J. Gen. Virol. 67:2325-2334.
39. McMichael, A. 1994. Cytoloxic T lymphocytes specific for influenza virus. Curr. Top. Microbiol. Immunol. 189:75-91.
40. Paglia, P., C. Chiodoni, M. Rodolfo, and M.P. Colombo. 1996. Murine dendritic cells loaded in vitro with soluble protein prime CTL against tumor antigen in vivo. J. Exp. Med. 183:317-322.
41. Mayordomo, J.I., T. Zorina, W.J. Storkus, L. Zitvogel, C. Celluzzi, L.D. Falo, C.J. Melief, S.T. Ilslad, W.M. Kast, A.B. DeLeo, and M.T. Lotze. 1995. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med. 1:1297-1302.
42. Celluzzi, C.M., J.I. Mayordomo, W.J. Storkus, M.T. Lotze, and L.D. Falo, Jr. 1996. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 183:283-287.
43. Orange, J.S., T.P. Salazar-Mather, S.M. Opal, R.L. Spencer, A.H. Miller, B.S. McEwen, and C.A. Biron. 1995. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181:901-914.